Sanofi is set to acquire DR-0201 from Dren Bio for up to $1.9 billion, aiming to expand its autoimmune disease pipeline with ...

A rare case has been reported of a patient with monoclonal gammopathy of undetermined significance (MGUS) who developed COVID-19-associated cold agglutinin syndrome (CAS), a condition that resembles ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.

and cold agglutinin disease (CAD), with slightly earlier programmes in haematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) and amyotrophic lateral sclerosis ...

EMPAVELI's unique mechanism of targeting C3 broadens its applicability beyond PNH, including other complement-driven diseases like geographic atrophy and immune complex-mediated diseases. With ...

trigger mild cold-like symptoms. But in infants and seniors, these viruses can ... New Roles in Infectious Process for Molecule That Inhibits Flu Nov. 14, 2024 — Researchers have identified new ...

Scientists have warned there is a 'severe risk' of catching a cold this week as nine million people across Britain suffer from the virus. They issued the health alert as the recent icy weather ...

BRISBANE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...